{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:08:39Z","timestamp":1781093319380,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.abd.2026.501357","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:16:00Z","timestamp":1778501760000},"page":"501357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of tofacitinib in the treatment of refractory palmoplantar psoriasis (non-pustular): case report and literature review"],"prefix":"10.1016","volume":"101","author":[{"given":"Paula Hitomi","family":"Sakiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane Donida Bartoli","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9294","authenticated-orcid":false,"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501357_bib0005","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaad.2008.11.910","article-title":"Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool","volume":"60","author":"Farley","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2026.501357_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40257-024-00849-0","article-title":"Small-molecule inhibitors and biologics for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis","volume":"25","author":"Huang","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2026.501357_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jid.2022.05.1094","article-title":"Comparison of the inflammatory circuits in psoriasis vulgaris, non-pustular palmoplantar psoriasis, and palmoplantar pustular psoriasis","volume":"143","author":"Wang","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2026.501357_bib0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","article-title":"JAK-STAT pathway inhibitors in dermatology","volume":"98","author":"Miot","year":"2023","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2026.501357_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.55563\/clinexprheumatol\/xdcraa","article-title":"Successful treatment of refractory palmoplantar psoriasis in a psoriatic arthritis patient with the JAK inhibitor tofacitinib","volume":"39","author":"Valor-M\u00e9ndez","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.abd.2026.501357_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/2475530321995516","article-title":"Tofacitinib for the treatment of refractory palmoplantar psoriasis: a case series","volume":"6","author":"Muzumdar","year":"2021","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"10.1016\/j.abd.2026.501357_bib0035","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2399220","article-title":"Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis","volume":"35","author":"De Luca","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2026.501357_bib0040","article-title":"Palmoplantar plaque psoriasis responsive to upadacitinib: a report of two cases","volume":"13","author":"Choi","year":"2025","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.abd.2026.501357_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2025.103404","article-title":"Upadacitinib for management of concomitant palmoplantar psoriasis and alopecia areata associated with common variable immunodeficiency","volume":"152","author":"Hardy","year":"2025","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.abd.2026.501357_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/12034754241238707","article-title":"Efficacy and safety of JAK inhibitors in treating refractory palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review","volume":"28","author":"Rijal","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.abd.2026.501357_bib0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0560.2007.00782.x","article-title":"Non-pustular palmoplantar psoriasis: is histologic differentiation from eczematous dermatitis possible?","volume":"35","author":"Aydin","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.abd.2026.501357_bib0060","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamadermatol.2019.1268","article-title":"Morphologic switch from psoriasiform to eczematous dermatitis after anti-IL-17 therapy: a case series","volume":"155","author":"Lai","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2026.501357_bib0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00403-024-03438-7","article-title":"Th1 and Th2 cytokine expression in hyperkeratotic chronic hand eczema and the role of tofacitinib, an oral JAK inhibitor","volume":"316","author":"Sardana","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2026.501357_bib0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036505962600070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036505962600070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:39:22Z","timestamp":1781091562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036505962600070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S036505962600070X"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501357","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of tofacitinib in the treatment of refractory palmoplantar psoriasis (non-pustular): case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501357"}}